David W. Robertson Endowment Fund Supported by Pfizer and Friends

The David W. Robertson Endowment Fund was established in 2003 by Pfizer, Inc. to provide graduate fellowships in memory of Illinois Chemistry alumnus and Pfizer employee David W. Robertson (M.S., '78; Ph.D., '81; Katzenellenbogen).

Dr. Robertson had a highly successful career and an international reputation as a scientist. He published more than 120 papers and held more than 60 U.S. patents. He and his research teams were responsible for placing more than 40 new drug candidates into clinical development. Robertson was also one of the inventors of Cymbalta, a mechanistically-novel medication for the treatment of depressive illness that accounted for as much as 22% of Lilly's sales at one point.